| Select | PubMed ID | Description |
| 22677622 | Int Arch Allergy Immunol. 2012;159(2):209-12. doi: 10.1159/000336027. Epub
2012 Jun 1.
Anaphylaxis to peanut in a patient predominantly sensitized to Ara h 6.
Asarnoj A(1), Glaumann S, Elfström L, Lilja G, Lidholm J, Nilsson C, Wickman M.
Author information:
|
| 22738678 | J Allergy Clin Immunol. 2012 Aug;130(2):468-72. doi:
1016/j.jaci.2012.05.019. Epub 2012 Jun 26.
Peanut component Ara h 8 sensitization and tolerance to peanut.
Asarnoj A(1), Nilsson C, Lidholm J, Glaumann S, Östblom E, Hedlin G, van Hage M,
Lilja G, Wickman M.
Author information:
|
| 24813113 | Allergy. 2014 Aug;69(8):1112-4. doi: 10.1111/all.12424. Epub 2014 May 9.
The diagnostic accuracy of specific IgE to Ara h 6 in adults is as good as Ara h
Klemans RJ(1), Knol EF, Bruijnzeel-Koomen CA, Knulst AC.
Author information:
|
| 25765158 | Int Arch Allergy Immunol. 2015;166(1):13-24. doi: 10.1159/000371422. Epub 2015
Feb 27.
Component-resolved IgE profiles in Austrian patients with a convincing history
of peanut allergy.
Ackerbauer D(1), Bublin M, Radauer C, Varga EM, Hafner C, Ebner C, Szépfalusi Z,
Fröschl R, Hoffmann-Sommergruber K, Eiwegger T, Breiteneder H.
Author information:
|
| 28120602 | Eur Ann Allergy Clin Immunol. 2017 Jan;49(1):18-21.
Ara h 6 sensitization in peanut allergy: friend, foe or innocent bystander?
Tontini C(1), Marinangeli L(2), Maiello N(3), Abbadessa S(4), Villalta D(5),
Antonicelli L(2).
Author information:
|
| 30368492 | Int Arch Allergy Immunol. 2019;178(1):66-75. doi: 10.1159/000493327. Epub 2018
Oct 26.
Ara h 1 and Ara h 6 Sensitization Causes Clinical Peanut Allergy in Ara h
2-Negative Individuals.
Magnusdottir H(1)(2), Vidarsdóttir AG(2), Ludviksson BR(1)(2)(3), Clausen
M(4)(3), Lund SH(5), Jensen AB(6), Sigurdardottir ST(7)(8)(9).
Author information:
|
| 30561805 | Pediatr Allergy Immunol. 2019 Mar;30(2):248-252. doi: 10.1111/pai.13012. Epub
2019 Jan 31.
Peanut oral immunotherapy increases IgG4 to Ara h 1, 2, and 6 but does not
affect IgG4 to other allergens.
Uotila R(1), Kukkonen AK(1), Greco D(2)(3), Pelkonen AS(1), Mäkelä MJ(1).
Author information:
|
| 32298698 | J Allergy Clin Immunol. 2020 Sep;146(3):621-630.e5. doi:
1016/j.jaci.2020.03.026. Epub 2020 Apr 13.
Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6.
Hemmings O(1), Du Toit G(2), Radulovic S(2), Lack G(3), Santos AF(4).
Author information:
|
| 33217527 | Food Chem Toxicol. 2021 Jan;147:111866. doi: 10.1016/j.fct.2020.111866. Epub
2020 Nov 17.
Purification of soybean cupins and comparison of IgE binding with peanut
allergens in a population of allergic subjects.
Ramadan S(1), Marsh J(2), El-Sherbeny GA(1), El-Halawany EF(1), Luan F(3),
Baumert JL(2), Johnson P(2), Osman Y(1), Goodman RE(4).
Author information:
|
| 34037388 | J Agric Food Chem. 2021 Jun 9;69(22):6318-6329. doi: 10.1021/acs.jafc.1c00618.
Epub 2021 May 26.
Purification and Initial Characterization of Ara h 7, a Peanut Allergen from the
2S Albumin Protein Family.
Apostolovic D(1), Marsh JT(2), Baumert J(2), Taylor SL(2), Westphal A(3), de
Jongh H(4), Johnson P(2), de Jong GAH(5), Koppelman SJ(2).
Author information:
|
| 34492400 | J Allergy Clin Immunol Pract. 2022 Jan;10(1):189-199. doi:
1016/j.jaip.2021.08.029. Epub 2021 Sep 4.
Combining Allergen Components Improves the Accuracy of Peanut Allergy Diagnosis.
Hemmings O(1), Niazi U(2), Kwok M(1), Radulovic S(3), Du Toit G(3), Lack G(4),
Santos AF(5).
Author information:
|
| 37028524 | J Allergy Clin Immunol. 2023 Apr 5:S0091-6749(23)00426-8. doi:
1016/j.jaci.2023.03.025. Online ahead of print.
IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex
formation of both major peanut allergens.
Warmenhoven HJM(1), Hulsbos L(2), Dreskin SC(3), Akkerdaas JH(4), Versteeg
SA(4), van Ree R(5).
Author information:
|
| 37038893 | Clin Exp Allergy. 2023 Jun;53(6):636-647. doi: 10.1111/cea.14314. Epub 2023
Apr 11.
Ara h 2-specific IgE epitope-like peptides inhibit the binding of IgE to Ara h 2
and suppress lgE-dependent effector cell activation.
Korošec P(1)(2)(3), Koren A(1), Debeljak J(1), Zahirović A(2),
Skerbinjek-Kavalar M(4), Berce V(4), Dejanović L(1), Luzar J(2), Štrukelj B(2),
Lunder M(2).
Author information:
|
